clinical trial · NCT06135415
A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis
Almirall, S.A.·phase3·completed·n = 280
Keratosis, ActinicTirbanibulinVehicle ointment
brief summary
The purpose of the study is to evaluate the efficacy and safety of tirbanibulin 10 milligrams per gram (mg/g) ointment when applied to a treatment field (TF) larger than 25 centimeter square (cm\^2) and up to 100 cm\^2 in adult participants with actinic keratosis (AK).
started
Dec 21, 2023
primary completion
Apr 30, 2025
completion
Nov 25, 2025
last updated
Mar 25, 2026
official title
A Phase 3, Multicentre, Randomised, Double-blind, Vehicle-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Tirbanibulin 10 mg/g Ointment Applied to a Treatment Field Larger Than 25 cm^2 and up to 100 cm^2 in Adult Patients With Actinic Keratosis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol